GONAL-f (follitropin alfa injection) is a recombinant human follicle-stimulating hormone (r-hFSH) approved for the treatment female infertility and a rare form of male infertility. Merck announced ...

Merck Serono announced that the FDA has approved EMD Serono‘s GONAL-f RFF Redi-ject (recombinant follitropin alfa) injection, a disposable prefilled drug injector pen indicated for the subcutaneous ...

New pen is easy-to-learn and easy-to-use, supporting the one in six couples affected by infertility in the U.S. [1] Insights of patients, nurses and doctors helped to evolve the product Merck, a ...

GENEVA, July 4, 2011 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that the European Commission (EC) has granted an approval for three pre-filled, ...

Geneva, Switzerland and Rockland, MA, May 27, 2004 -- Serono, Inc., the US affiliate of Serono (virt-x: SEO and NYSE: SRA), announced today that the United States Food and Drug Administration (FDA) ...

GENEVA, Switzerland, July 16 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that the Japanese Ministry of Health, Labor and Welfare has granted approval to ...

Haselmeier announces the launch by Merck of their GONAL-f® 2.0 prefilled pen following approval by EMA, the European Medicines Agency. Originally launched in 2011 by Merck, a leading science and ...

Add articles to your saved list and come back to them any time. A prefilled, disposable "pen" for injecting one of the key hormones used in IVF treatment is making the stress of daily jabs a little ...

- New pen is easy-to-learn and easy-to-use, supporting the one in six couples affected by infertility in the U.S.[1] - Insights of patients, nurses and doctors helped to evolve the product Merck, a ...

The New GONAL-f® Prefilled Pen (PRNewsfoto/Merck KGaA) Merck, a leading science and technology company, today announced that the company received approval for a new version of GONAL- f® (follitropin ...